相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease
Partow Kebriaei et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Haploidentical Transplantation with Post-Transplant Cyclophosphamide versus Unrelated Donor Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
Leonardo Javier Arcuri et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide
Shannon R. McCurdy et al.
BLOOD (2019)
Donor-derived marrow mesenchymal stromal cell co-transplantation following a haploidentical hematopoietic stem cell transplantation trail to treat severe aplastic anemia in children
Z. -K. Wang et al.
ANNALS OF HEMATOLOGY (2019)
Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition
Sheila A. Fisher et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease
Stephanie J. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease
Paul J. Martin et al.
BLOOD (2017)
Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Current Use and Trends in Hematopoietic Cell Transplantation in the United States
Anita D'Souza et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease
Paul J. Martin et al.
BLOOD (2017)
Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results (vol 52, pg 704, 2017)
Z. Liu et al.
BONE MARROW TRANSPLANTATION (2017)
Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome
Felix von Dalowski et al.
STEM CELLS (2016)
Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
Mukta Arora et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Phase II Multicenter, Randomized, Double-Blind Controlled Study of Efficacy and Safety of Umbilical Cord-Derived Mesenchymal Stromal Cells in the Prophylaxis of Chronic Graft-Versus-Host Disease After HLA-Haploidentical Stem-Cell Transplantation
Lei Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
Sally Arai et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
How we treat chronic graft-versus-host disease
Mary E. D. Flowers et al.
BLOOD (2015)
Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies Using a Reduced-Intensity Conditioning Regimen and Third-Party Mesenchymal Stromal Cells
Sandhya Kharbanda et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
Boglarka Gyurkocza et al.
BLOOD (2014)
Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity
Soo Young Kim et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Treatment and management of graft-versus-host disease: improving response and survival
Catherine Garnett et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)
Steroid-Refractory Acute GVHD: Lack of Long-Term Improved Survival Using New Generation Anticytokine Treatment
Alienor Xhaard et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Risk factors for acute GVHD and survival after hematopoietic cell transplantation
Madan Jagasia et al.
BLOOD (2012)
Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT
Edus H. Warren et al.
BLOOD (2012)
Diagnosis and management of acute graft-versus-host disease
Fiona L. Dignan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation
M. E. Bernardo et al.
BONE MARROW TRANSPLANTATION (2011)
Have we improved in preventing and treating acute graft-versus-host disease?
Lia Perez et al.
CURRENT OPINION IN HEMATOLOGY (2011)
Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Joseph Pidala et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Prophylaxis regimens for GVHD: systematic review and meta-analysis
R. Ram et al.
BONE MARROW TRANSPLANTATION (2009)
Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial
M. L. MacMillan et al.
BONE MARROW TRANSPLANTATION (2009)
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium
M. von Bonin et al.
BONE MARROW TRANSPLANTATION (2009)
Graft-versus-host disease
James L. M. Ferrara et al.
LANCET (2009)
Current and novel therapies in acute GVHD
Vincent T. Ho et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study
H. Ning et al.
LEUKEMIA (2008)
Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation
Lynne M. Ball et al.
BLOOD (2007)
Treatment of acute graft-versus-host disease with prednisolone:: significant survival advantage for day+5 responders and no advantage for nonresponders receiving anti-thymocyte globulin
Maria Teresa Van Lint et al.
BLOOD (2006)
Medical progress: Hematopoietic stem-cell transplantation
EA Copelan
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients
HM Lazarus et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Human mesenchymal stem cells modulate allogeneic immune cell responses
S Aggarwal et al.
BLOOD (2005)
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
K Le Blanc et al.
LANCET (2004)
Duration of immunosuppressive treatment for chronic graft-versus-host disease
BL Stewart et al.
BLOOD (2004)
Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: Comparison of grading systems
ML MacMillan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
分享论文
